Crossmark

Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US

Crossref DOI link: https://doi.org/10.1186/s12876-015-0320-4

Published Online: 2015-08-05

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Sai

Bastian, Nathaniel D.

Griffin, Paul M.
License Information

License valid from 2015-08-05
More Information

Article History

Received: 12 January 2015

Accepted: 16 July 2015

First Online: 5 August 2015